Insider Monkey·2026-03-07 02:47Core Insights - ARK Invest's stock portfolio for 2026 highlights a focus on disruptive innovation, with a total portfolio value of $15.07 billion as of Q4 2025, down from $16.80 billion in the previous quarter [2][3] Group 1: Portfolio Overview - The portfolio consists of 196 positions, reflecting a strategic shift towards increasing stakes in companies like Coinbase, CRISPR Therapeutics, and Tempus AI, while reducing positions in major names like Tesla and Shopify [2][3] - Cathie Wood, CEO and CIO of ARK Invest, anticipates strong deflationary pressures in 2026, particularly in energy, housing, and unit labor prices [3] Group 2: Top Stock Picks - Tempus AI, Inc. (NASDAQ:TEM): Stake value of $446.3 million, with a strategic partnership with Merck to enhance AI-driven precision medicine [8][9] - Teradyne, Inc. (NASDAQ:TER): Stake value of $456.1 million, with a recent revenue growth of 44% year-over-year to $1.08 billion in Q4 2025 [11][12] - Robinhood Markets, Inc. (NASDAQ:HOOD): Stake value of $543.6 million, reporting a record quarterly revenue of $1.28 billion for Q4, despite missing analyst estimates [14][17] - Advanced Micro Devices, Inc. (NASDAQ:AMD): Stake value of $551.4 million, with a recent price target increase following a strategic partnership with Meta [19][20] - CRISPR Therapeutics AG (NASDAQ:CRSP): Stake value of $551.8 million, with strong momentum in siRNA therapies and a recent revenue of $54 million for Q4 [23][26]